Sanofi (SNY) Long-Term Debt Issuances (2009 - 2026)

Sanofi has disclosed Long-Term Debt Issuances across 18 years of filings, most recently posting $4.9 billion for Q2 2026.

• In Q2 2026, Long-Term Debt Issuances fell 21.17% year-over-year to $4.9 billion; the TTM figure through Jun 2026 stood at $5.6 billion (up 471.72% YoY), while the FY2025 annual figure was $6.5 billion, changed N/A from the prior year.
• Long-Term Debt Issuances came in at $4.9 billion for Q2 2026 at Sanofi, up from -$2.2 billion in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $9.1 billion in Q4 2025 to a low of -$6.2 billion in Q3 2025.
• Average Long-Term Debt Issuances over 5 years is $59.3 million, with a median of -$805.0 million recorded in 2024.
• The largest YoY upside for Long-Term Debt Issuances was 972.79% in 2025 against a maximum downside of 223.15% in 2025.
• Over 5 years, Long-Term Debt Issuances stood at $1.3 billion in 2022, then slumped by 215.79% to -$1.5 billion in 2023, then rose by 28.3% to -$1.0 billion in 2024, then soared by 972.79% to $9.1 billion in 2025, then tumbled by 46.58% to $4.9 billion in 2026.
• Per Business Quant data, the three most recent Long-Term Debt Issuances figures were $4.9 billion in Q2 2026, -$2.2 billion in Q1 2026, and $9.1 billion in Q4 2025.